A detailed history of Xtx Topco LTD transactions in Enlivex Therapeutics Ltd. stock. As of the latest transaction made, Xtx Topco LTD holds 22,659 shares of ENLV stock, worth $23,112. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,659
Previous 24,820 8.71%
Holding current value
$23,112
Previous $35,000 8.57%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.2 - $1.69 $2,593 - $3,652
-2,161 Reduced 8.71%
22,659 $38,000
Q2 2024

Aug 12, 2024

BUY
$1.27 - $4.31 $31,521 - $106,974
24,820 New
24,820 $35,000

Others Institutions Holding ENLV

About Enlivex Therapeutics Ltd.


  • Ticker ENLV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 18,403,200
  • Market Cap $18.8M
  • Description
  • Enlivex Therapeutics Ltd. operates as a clinical-stage macrophage reprogramming immunotherapy company. It is developing Allocetra, a cell-based therapy to treat organ dysfunction and failure associated with sepsis that is in phase II clinical trial, as well as in preclinical trial to treat solid tumors. Enlivex Therapeutics Ltd. was founded in 2...
More about ENLV
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.